Literature DB >> 18094258

The impact of catechol-O-methyltransferase and dopamine D4 receptor genotypes on neurophysiological markers of performance monitoring.

Ulrike M Krämer1, Toni Cunillera, Estela Càmara, Josep Marco-Pallarés, David Cucurell, Wido Nager, Peter Bauer, Rebecca Schüle, Ludger Schöls, Antoni Rodriguez-Fornells, Thomas F Münte.   

Abstract

Dynamic adaptations of one's behavior by means of performance monitoring are a central function of the human executive system, that underlies considerable interindividual variation. Converging evidence from electrophysiological and neuroimaging studies in both animals and humans hints at the importance of the dopaminergic system for the regulation of performance monitoring. Here, we studied the impact of two polymorphisms affecting dopaminergic functioning in the prefrontal cortex [catechol-O-methyltransferase (COMT) Val108/158Met and dopamine D4 receptor (DRD4) single-nucleotide polymorphism (SNP)-521] on neurophysiological correlates of performance monitoring. We applied a modified version of a standard flanker task with an embedded stop-signal task to tap into the different functions involved, particularly error monitoring, conflict detection and inhibitory processes. Participants homozygous for the DRD4 T allele produced an increased error-related negativity after both choice errors and failed inhibitions compared with C-homozygotes. This was associated with pronounced compensatory behavior reflected in higher post-error slowing. No group differences were seen in the incompatibility N2, suggesting distinct effects of the DRD4 polymorphism on error monitoring processes. Additionally, participants homozygous for the COMT Val allele, with a thereby diminished prefrontal dopaminergic level, revealed increased prefrontal processing related to inhibitory functions, reflected in the enhanced stop-signal-related components N2 and P3a. The results extend previous findings from mainly behavioral and neuroimaging data on the relationship between dopaminergic genes and executive functions and present possible underlying mechanisms for the previously suggested association between these dopaminergic polymorphisms and psychiatric disorders as schizophrenia or attention deficit hyperactivity disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094258      PMCID: PMC6673506          DOI: 10.1523/JNEUROSCI.4229-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

1.  Monitoring antisaccades: inter-individual differences in cognitive control and the influence of COMT and DRD4 genotype variations.

Authors:  Emmanouil Kattoulas; Ioannis Evdokimidis; Nicholas C Stefanis; Dimitrios Avramopoulos; Costas N Stefanis; Nikolaos Smyrnis
Journal:  Exp Brain Res       Date:  2010-04-24       Impact factor: 1.972

2.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

3.  Monoaminergic modulation of behavioural and electrophysiological indices of error processing.

Authors:  Jessica J M Barnes; Redmond G O'Connell; L Sanjay Nandam; Angela J Dean; Mark A Bellgrove
Journal:  Psychopharmacology (Berl)       Date:  2013-08-31       Impact factor: 4.530

4.  Acute effects of cocaine on the neurobiology of cognitive control.

Authors:  Hugh Garavan; Jacqueline N Kaufman; Robert Hester
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 5.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

6.  Impact of orbitofrontal lesions on electrophysiological signals in a stop signal task.

Authors:  Anne-Kristin Solbakk; Ingrid Funderud; Marianne Løvstad; Tor Endestad; Torstein Meling; Magnus Lindgren; Robert T Knight; Ulrike M Krämer
Journal:  J Cogn Neurosci       Date:  2014-01-06       Impact factor: 3.225

7.  Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.

Authors:  Kevin R Krull; Deepa Bhojwani; Heather M Conklin; Deqing Pei; Cheng Cheng; Wilburn E Reddick; John T Sandlund; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

8.  Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhood.

Authors:  Maureen E Bowers; George A Buzzell; Virginia Salo; Sonya V Troller-Renfree; Colin A Hodgkinson; David Goldman; Elena Gorodetsky; Jennifer Martin McDermott; Heather A Henderson; Nathan A Fox
Journal:  Dev Psychobiol       Date:  2019-08-01       Impact factor: 3.038

Review 9.  The genetics of anxiety-related negative valence system traits.

Authors:  Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-19       Impact factor: 3.568

10.  The role of limbic system irritability in linking history of childhood maltreatment and psychiatric outcomes in low-income, high-risk women: moderation by FK506 binding protein 5 haplotype.

Authors:  Melissa N Dackis; Fred A Rogosch; Assaf Oshri; Dante Cicchetti
Journal:  Dev Psychopathol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.